LISATA THERAPEUTICS, INC. Increase (Decrease) in Fair Value of Interest Rate Fair Value Hedging Instruments (Deprecated 2012-01-31)
LISATA THERAPEUTICS, INC. (LSTA) reported Increase (Decrease) in Fair Value of Interest Rate Fair Value Hedging Instruments (Deprecated 2012-01-31) of -$6.20 thousand for the 3-month period ending 2012-09-30, per its 10-Q filed 2012-11-13.
Discontinued › Notes
us-gaap:IncreaseDecreaseInFairValueOfInterestRateFairValueHedgingInstruments · last filed 2012-11-13
- LISATA THERAPEUTICS, INC. increase (decrease) in fair value of interest rate fair value hedging instruments (deprecated 2012-01-31) for the quarter ending 2012-09-30 was -$6.20K, a 108.76% decline year-over-year.
- LISATA THERAPEUTICS, INC. increase (decrease) in fair value of interest rate fair value hedging instruments (deprecated 2012-01-31) for the quarter ending 2012-06-30 was -$52.10K, a 286.74% decline year-over-year.
- LISATA THERAPEUTICS, INC. increase (decrease) in fair value of interest rate fair value hedging instruments (deprecated 2012-01-31) for the quarter ending 2011-09-30 was $70.80K.
- LISATA THERAPEUTICS, INC. increase (decrease) in fair value of interest rate fair value hedging instruments (deprecated 2012-01-31) for the quarter ending 2011-06-30 was $27.90K.
| Period end | Increase (Decrease) in Fair Value of Interest Rate Fair Value Hedging Instruments (Deprecated 2012-01-31) 3 month | Increase (Decrease) in Fair Value of Interest Rate Fair Value Hedging Instruments (Deprecated 2012-01-31) 6 month | Increase (Decrease) in Fair Value of Interest Rate Fair Value Hedging Instruments (Deprecated 2012-01-31) 9 month |
|---|---|---|---|
| 2012-09-30 | -$6.20K 10-Q · filed 2012-11-13 | -$134.80K 10-Q · filed 2012-11-13 | |
| 2012-06-30 | -$52.10K 10-Q · filed 2012-08-14 | -$128.50K 10-Q · filed 2012-08-14 | |
| 2011-09-30 | $70.80K 10-Q · filed 2012-11-13 | $87.90K 10-Q · filed 2012-11-13 | |
| 2011-06-30 | $27.90K 10-Q · filed 2012-08-14 | $17.00K 10-Q · filed 2012-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| BIOVIE INC. (BIVI) | United States | $0.012B |